RESPIMER® Netiflow® vs. Saline Solutions During Nasal Irrigation Following Bilateral Ethmoidectomy (Nasal Polyposis) (NETIFLOW)
Polyp of Ethmoidal Sinus, Surgery
About this trial
This is an interventional other trial for Polyp of Ethmoidal Sinus focused on measuring Saline Solution, Isotonic / Administration & dosage, Therapeutic Irrigation / methods, Postoperative Care / methods, Quality of life
Eligibility Criteria
Inclusion Criteria:
- Males or females between 18 and 65 years of age
Subject in need of sinus surgery as bilateral total ethmoidectomy using an endoscopic endonasal approach whose pathology is the result of a:
- Sinonasal polyposis alone
- Sinonasal polyposis associated with asthma and / or intolerance to NSAIDs
- Free and informed written consent
- Member or beneficiary of a social security program
Exclusion Criteria:
- Oral corticosteroid treatment since less than 2 months
- Premenopausal women not using effective contraception (oral or intrauterine device)
- Pregnant or nursing women
- Uncontrolled diabetes (not treated or stabilized by treatment)
- HIV-positive status
- Autoimmune diseases affecting the nose and/or sinuses, immune dysfunctions (Wegener's granulomatosis, Churg-Strauss syndrome, Common Variable Immunodeficiency, sarcoidosis...), or malignant diseases (unclear histology)
- All contraindication of RESPIMER® NetiFlow®
- All diseases resulting in difficulty coughing or swallowing
- Ongoing or past radiation treatment to the head and neck
- Ongoing or recent chemotherapy (within a three-month period)
- Subjects using anticoagulants
- Subjects taking part in another study that includes an exclusion period coinciding with that of the run-in period of this study
- Subjects placed under judicial protection
- Subjects who suffer from severe physical or psychological problems and whose condition can, according to the investigator, affect compliance with the study
Sites / Locations
- Service d'Oto-rhino-laryngologie - Clinique Saint-Augustin
- Service d'Oto-rhino-laryngologie et Chirurgie cervico-faciale - Hôpital Pellegrin
- ORL et Chirurgie Cervico-faciale - Pôle Voies Respiratoires - CHU Toulouse
- Service d'ORL et Chirurgie cervico faciale - CHRU Tours
- Service d'oto-rhino-laryngologie - CHU de Nantes
- Service ORL et Chirurgie Cervico-faciale - CHRU Nancy
- Service ORL et Chirurgie cervico-faciale - CHRU Lille
- ORL et Chirurgie Cervico-faciale - Centre Hospitalier Intercommunal (CHI) de Créteil
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
A - Experimental
B - Comparator
Treatment Arm: 100 patients using Respimer® NetiFlow® solution as standard treatment for healing of nasal surgery wounds following an endoscopic ethmoidectomy as a postoperative care after ethmoid sinus surgery
Control Arm: 100 patients using saline solution (0.9% NaCl) as standard treatment for healing of nasal surgery wounds following an endoscopic ethmoidectomy as a postoperative care after ethmoid sinus surgery